What medication regimen would you recommend for a 72-year-old white female with stage 2 hypertension who is currently taking metoprolol?

Management of Stage 2 Hypertension in a 72-Year-Old on Metoprolol

Add an ACE inhibitor or ARB to the current metoprolol regimen, followed by a dihydropyridine calcium channel blocker or thiazide-like diuretic if blood pressure remains uncontrolled.

Clinical Context

This patient presents with stage 2 hypertension (170/101 mmHg) on beta-blocker monotherapy, requiring immediate intensification of therapy. At 72 years old, she falls within the age range where aggressive blood pressure control reduces cardiovascular morbidity and mortality 1.

Recommended Treatment Algorithm

Step 1: Add First-Line Agent to Metoprolol

• Initiate a low-dose ACE inhibitor or ARB as the next agent 1
• For non-Black patients, the 2020 International Society of Hypertension guidelines recommend ACE inhibitors or ARBs as first-line therapy, with beta-blockers reserved for specific indications or as add-on therapy 1
• Beta-blockers like metoprolol are not preferred as initial monotherapy but are appropriate when combined with other major drug classes 1

Step 2: Escalate to Three-Drug Combination if Needed

If blood pressure remains ≥140/90 mmHg after adding an ACE inhibitor/ARB:

• Add a dihydropyridine calcium channel blocker (e.g., amlodipine) OR a thiazide-like diuretic (e.g., chlorthalidone, indapamide) 1
• The preferred three-drug combination is: RAS blocker (ACE inhibitor/ARB) + dihydropyridine CCB + thiazide/thiazide-like diuretic 1
• Consider single-pill combinations to improve adherence 1

Step 3: Consider Replacing Metoprolol

Important caveat: While the current guidelines support adding to metoprolol, consider whether this patient has a compelling indication for beta-blocker therapy 1. If she lacks conditions such as:

• Angina pectoris
• Post-myocardial infarction status
• Heart failure with reduced ejection fraction
• Atrial fibrillation requiring rate control

Then replacing metoprolol with a more evidence-based first-line agent may be more appropriate 1. The 2017 ACC/AHA guidelines note that beta-blockers were significantly less effective than diuretics for stroke prevention and cardiovascular events in elderly patients 1.

Blood Pressure Targets for This Patient

• Target systolic BP: 120-129 mmHg if well tolerated 1
• For a 72-year-old, individualize based on frailty status, but aim for at least <140/90 mmHg 1
• The 2024 ESC guidelines recommend targeting 120-129 mmHg in most adults to reduce cardiovascular risk 1
• Achieve target within 3 months of treatment initiation 1

Specific Drug Considerations in Elderly Patients

Thiazide-Like Diuretics

• Chlorthalidone demonstrated superiority over amlodipine and lisinopril in preventing heart failure in elderly hypertensive patients 1
• Thiazide diuretics are highly effective in isolated systolic hypertension common in this age group 2
• Monitor for hypokalemia and hyperuricemia 3

ACE Inhibitors/ARBs

• Well-tolerated in elderly patients 2
• Provide cardiovascular and renal protection 1
• ARBs may have fewer side effects (less cough, angioedema) than ACE inhibitors 1

Calcium Channel Blockers

• Dihydropyridine CCBs (amlodipine, felodipine) are effective and well-tolerated in elderly patients 4, 2
• Particularly useful when combined with beta-blockers, as they have complementary mechanisms 5, 4

Practical Implementation

Recommended initial prescription:

• Continue metoprolol at current dose
• Add lisinopril 10 mg daily OR losartan 25-50 mg daily 1
• Recheck blood pressure in 2-4 weeks

If BP remains ≥140/90 mmHg at follow-up:

• Add amlodipine 5 mg daily OR chlorthalidone 12.5 mg daily 1
• Consider single-pill combination products to enhance adherence 1

Alternative approach if no compelling indication for beta-blocker:

• Transition from metoprolol to a two-drug combination of ACE inhibitor/ARB + CCB or thiazide-like diuretic 1
• This aligns better with guideline-recommended first-line therapy for non-Black patients 1

Monitoring Requirements

• Recheck BP within 2-4 weeks of any medication change 1
• Monitor serum potassium and creatinine when adding ACE inhibitor/ARB or diuretic 1
• Assess for orthostatic hypotension, particularly important in elderly patients 1
• Confirm adherence at each visit 1

Common Pitfalls to Avoid

• Do not combine two RAS blockers (ACE inhibitor + ARB) - this is not recommended and increases adverse events without additional benefit 1
• Avoid inadequate dosing - ensure medications are titrated to effective doses before adding additional agents 1
• Do not delay treatment intensification - stage 2 hypertension (≥160/100 mmHg) requires immediate pharmacological intervention 1
• Monitor for excessive BP lowering in elderly patients, particularly if frail, but do not withhold appropriate therapy based solely on age 1